vai alle Pubblicazioni
Publications prior to 2004
1. Pasqualucci L,
Wasik M, Teicher BA, Flenghi L, Bolognesi A, Stirpe F, Polito L,
Falini B, Kadin ME. Antitumor activity of anti-CD30 immunotoxin
(Ber-H2/saporin) in vitro and in severe combined immunodeficiency
disease mice xenografted with human CD30+ anaplastic large-cell
lymphoma. Blood. 1995 Apr 15;85(8):2139-46.
2. Battelli MG,
Buonamici L, Polito L, Bolognesi A, Stirpe F. Hepatoxicity of
ricin, saporin or a saporin immunotoxin: xanthine oxidase activity
in rat liver and blood serum. Virchows Arch. 1996
Feb;427(5):529-35.
3. Battelli MG,
Polito L, Bolognesi A, Lafleur L, Fradet Y, Stirpe F. Toxicity of
ribosome-inactivating proteins-containing immunotoxins to a human
bladder carcinoma cell line. Int J Cancer. 1996 Feb
8;65(4):485-90.
4. Terenzi A,
Bolognesi A, Pasqualucci L, Flenghi L, Pileri S, Stein H, Kadin M,
Bigerna B, Polito L, Tazzari PL, Martelli MF, Stirpe F, Falini B.
Anti-CD30 (BER=H2) immunotoxins containing the type-1
ribosome-inactivating proteins momordin and PAP-S (pokeweed
antiviral protein from seeds) display powerful antitumour activity
against CD30+ tumour cells in vitro and in SCID mice. Br J
Haematol. 1996 Mar;92(4):872-9.
5. Stirpe F,
Barbieri L, Gorini P, Valbonesi P, Bolognesi A, Polito L.
Activities associated with the presence of ribosome-inactivating
proteins increase in senescent and stressed leaves.FEBS Lett. 1996
Mar 18;382(3):309-12.
6. Vooijs WC, Post
J, Wijdenes J, Schuurman HJ, Bolognesi A, Polito L, Stirpe F, Bast
EJ, de Gast GC. Efficacy and toxicity of plasma-cell-reactive
monoclonal antibodies B-B2 and B-B4 and their immunotoxins. Cancer
Immunol Immunother. 1996 Jul;42(6):319-28.
7. Bolognesi A,
Tazzari PL, Olivieri F, Polito L, Falini B, Stirpe F. Induction of
apoptosis by ribosome-inactivating proteins and related
immunotoxins. Int J Cancer. 1996 Nov 4;68(3):349-55.
8. Di Massimo AM, Di
Loreto M, Pacilli A, Raucci G, D'Alatri L, Mele A, Bolognesi A,
Polito L, Stirpe F, De Santis R. Immunoconjugates made of an
anti-EGF receptor monoclonal antibody and type 1
ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria
pyramidata. Br J Cancer. 1997;75(6):822-8.
9. Battelli MG,
Barbieri L, Bolognesi A, Buonamici L, Valbonesi P, Polito L, Van
Damme EJ, Peumans WJ, Stirpe F. Ribosome-inactivating lectins with
polynucleotide:adenosine glycosidase activity. FEBS Lett. 1997 May
26;408(3):355-9.
10. Vooijs WC, Otten HG, van Vliet M,
van Dijk AJ, de Weger RA, de Boer M, Bohlen H, Bolognesi A, Polito
L, de Gast GC. B7-1 (CD80) as target for immunotoxin therapy for
Hodgkin's disease. Br J Cancer. 1997;76(9):1163-9.
11. Bolognesi A, Polito L, Olivieri F,
Valbonesi P, Barbieri L, Battelli MG, Carusi MV, Benvenuto E, Del
Vecchio Blanco F, Di Maro A, Parente A, Di Loreto M, Stirpe F. New
ribosome-inactivating proteins with polynucleotide:adenosine
glycosidase and antiviral activities from Basella rubra L. and
bougainvillea spectabilis Willd. Planta. 1997 Dec;203(4):422-9.
12. Battelli MG, Bolognesi A, Olivieri
F, Polito L, Stirpe F. Different sensitivity of CD30+ cell lines to
Ber-H2/saporin-S6 immunotoxin. J Drug Target. 1998;5(3):181-91.
13. Bolognesi A, Tazzari PL, Olivieri
F, Polito L, Lemoli R, Terenzi A, Pasqualucci L, Falini B, Stirpe
F. Evaluation of immunotoxins containing single-chain
ribosome-inactivating proteins and an anti-CD22 monoclonal antibody
(OM124): in vitro and in vivo studies. Br J Haematol. 1998
Apr;101(1):179-88.
14. Valbonesi P, Barbieri L, Bolognesi
A, Bonora E, Polito L, Stirpe F. Preparation of highly purified
momordin II without ribonuclease activity. Life Sci.
1999;65(14):1485-91.
15. Bolognesi A, Polito L, Tazzari PL,
Lemoli RM, Lubelli C, Fogli M, Boon L, de Boer M, Stirpe F. In
vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins
containing type 1 ribosome-inactivating proteins. Br J Haematol.
2000 Aug;110(2):351-61.
16. Barbieri L, Bolognesi A, Valbonesi
P, Polito L, Olivieri F, Stirpe F. Polynucleotide: adenosine
glycosidase activity of immunotoxins containing
ribosome-inactivating proteins. J Drug Target. 2000;8(5):281-8.
17. Di Maro A, Ferranti P,
Mastronicola M, Polito L, Bolognesi A, Stirpe F, Malorni A, Parente
A. Reliable sequence determination of ribosome- inactivating
proteins by combining electrospray mass spectrometry and Edman
degradation. J Mass Spectrom. 2001 Jan;36(1):38-46.
18. Pistillo MP, Tazzari PL, Stirpe F,
Bolognesi A, Polito L, Capanni P, Pioli C, Gatta L, Ubaldi V, Doria
G, Conte R, Ferrara GB. Anti-CTLA-4 human scFv antibodies prevent
T-cell activation in transplantation. Transplant Proc. 2001
Feb-Mar;33(1-2):285-7.
19. Tazzari PL, Polito L, Bolognesi A,
Pistillo MP, Capanni P, Palmisano GL, Lemoli RM, Curti A, Biancone
L, Camussi G, Conte R, Ferrara GB, Stirpe F. Immunotoxins
containing recombinant anti-CTLA-4 single-chain fragment variable
antibodies and saporin: in vitro results and in vivo effects in an
acute rejection model. J Immunol. 2001 Oct 15;167(8):4222-9.
20. Campos EC, Schiavi C, Bolognesi A,
Bellusci C, Lubelli C, Duca A, Polito L, Poulas K, Tzartos SJ,
Stirpe F. Selective lesions of rabbit extraocular muscles injected
with the anti-AChR immunotoxin saporin-mAb 73. Curr Eye Res. 2002
Jan;24(1):58-65.
21. Gosselaar PH, van-Dijk AJ, de-Gast
GC, Polito L, Bolognesi A, Vooijs WC, Verheul AF, Krouwer HG, Marx
JJ. Transferrin toxin but not transferrin receptor immunotoxin is
influenced by free transferrin and iron saturation. Eur J Clin
Invest. 2002 Mar;32 Suppl 1:61-9.
22. Bolognesi A, Polito L, Lubelli C,
Barbieri L, Parente A, Stirpe F. Ribosome-inactivating and adenine
polynucleotide glycosylase activities in Mirabilis jalapa L.
tissues. J Biol Chem. 2002 Apr 19;277(16):13709-16.
23. Ricci C, Polito L, Nanni P,
Landuzzi L, Astolfi A, Nicoletti G, Rossi I, De Giovanni C,
Bolognesi A, Lollini PL. HER/erbB receptors as therapeutic targets
of immunotoxins in human rhabdomyosarcoma cells. J Immunother. 2002
Jul-Aug;25(4):314-23.
24. Pistillo MP, Tazzari PL, Palmisano
GL, Pierri I, Bolognesi A, Ferlito F, Capanni P, Polito L, Ratta M,
Pileri S, Piccioli M, Basso G, Rissotto L, Conte R, Gobbi M, Stirpe
F, Ferrara GB. CTLA-4 is not restricted to the lymphoid cell
lineage and can function as a target molecule for apoptosis
induction of leukemic cells. Blood. 2003 Jan 1;101(1):202-9.
25. Fermani S, Falini G, Ripamonti A,
Bolognesi A, Polito L, Stirpe F. Crystallization and preliminary
X-ray diffraction analysis of two ribosome-inactivating proteins:
lychnin and dianthin 30. Acta Crystallogr D Biol Crystallogr. 2003
Jul;59(Pt 7):1227-9.
